Intraoperative assessment of sentinel nodes in mastectomy patients
Association of Breast Surgery ePoster Library. Choong J. 05/13/19; 257048; P004
Jia Choong

REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P004
Topic: Axilla
Introduction:Intraoperative sentinel node assessment was routinely offered to patients undergoing curative breast surgery with negative preoperative nodal status. Our previous audit showed 34% patients undergoing mastectomy had positive OSNA results. Axillary radiotherapy is now increasingly being offered to node positive patients with one or two positive sentinel nodes. The aim of this audit was to assess the rate of positive sentinel nodes in patients undergoing mastectomy. Methods :A retrospective audit of patients who underwent mastectomy from January 2015 to December 2017 was carried out. Mastectomy patients were identified from the Somerset Cancer Database, operative details and axillary treatment was recorded from the electronic patents records and analysed. Results: Of the 461 patients who underwent mastectomy, 183 patients underwent sentinel node biopsy and OSNA. Amongst the OSNA group, thirty five patients (19%) had positive sentinel node and underwent axillary clearance. Seventy one percent of these patients had only one or two positive nodes on final histology where axillary surgery could be avoided. On an average, only 3 patients per annum had more than 2 involved nodes on final histology who would benefit from further axillary treatment.Conclusion:Majority of patients with OSNA detected positive sentinel nodes had low nodal disease burden which could be easily managed with radiotherapy rather than axillary clearance.
Topic: Axilla
Introduction:Intraoperative sentinel node assessment was routinely offered to patients undergoing curative breast surgery with negative preoperative nodal status. Our previous audit showed 34% patients undergoing mastectomy had positive OSNA results. Axillary radiotherapy is now increasingly being offered to node positive patients with one or two positive sentinel nodes. The aim of this audit was to assess the rate of positive sentinel nodes in patients undergoing mastectomy. Methods :A retrospective audit of patients who underwent mastectomy from January 2015 to December 2017 was carried out. Mastectomy patients were identified from the Somerset Cancer Database, operative details and axillary treatment was recorded from the electronic patents records and analysed. Results: Of the 461 patients who underwent mastectomy, 183 patients underwent sentinel node biopsy and OSNA. Amongst the OSNA group, thirty five patients (19%) had positive sentinel node and underwent axillary clearance. Seventy one percent of these patients had only one or two positive nodes on final histology where axillary surgery could be avoided. On an average, only 3 patients per annum had more than 2 involved nodes on final histology who would benefit from further axillary treatment.Conclusion:Majority of patients with OSNA detected positive sentinel nodes had low nodal disease burden which could be easily managed with radiotherapy rather than axillary clearance.
P004
Topic: Axilla
Introduction:Intraoperative sentinel node assessment was routinely offered to patients undergoing curative breast surgery with negative preoperative nodal status. Our previous audit showed 34% patients undergoing mastectomy had positive OSNA results. Axillary radiotherapy is now increasingly being offered to node positive patients with one or two positive sentinel nodes. The aim of this audit was to assess the rate of positive sentinel nodes in patients undergoing mastectomy. Methods :A retrospective audit of patients who underwent mastectomy from January 2015 to December 2017 was carried out. Mastectomy patients were identified from the Somerset Cancer Database, operative details and axillary treatment was recorded from the electronic patents records and analysed. Results: Of the 461 patients who underwent mastectomy, 183 patients underwent sentinel node biopsy and OSNA. Amongst the OSNA group, thirty five patients (19%) had positive sentinel node and underwent axillary clearance. Seventy one percent of these patients had only one or two positive nodes on final histology where axillary surgery could be avoided. On an average, only 3 patients per annum had more than 2 involved nodes on final histology who would benefit from further axillary treatment.Conclusion:Majority of patients with OSNA detected positive sentinel nodes had low nodal disease burden which could be easily managed with radiotherapy rather than axillary clearance.
Topic: Axilla
Introduction:Intraoperative sentinel node assessment was routinely offered to patients undergoing curative breast surgery with negative preoperative nodal status. Our previous audit showed 34% patients undergoing mastectomy had positive OSNA results. Axillary radiotherapy is now increasingly being offered to node positive patients with one or two positive sentinel nodes. The aim of this audit was to assess the rate of positive sentinel nodes in patients undergoing mastectomy. Methods :A retrospective audit of patients who underwent mastectomy from January 2015 to December 2017 was carried out. Mastectomy patients were identified from the Somerset Cancer Database, operative details and axillary treatment was recorded from the electronic patents records and analysed. Results: Of the 461 patients who underwent mastectomy, 183 patients underwent sentinel node biopsy and OSNA. Amongst the OSNA group, thirty five patients (19%) had positive sentinel node and underwent axillary clearance. Seventy one percent of these patients had only one or two positive nodes on final histology where axillary surgery could be avoided. On an average, only 3 patients per annum had more than 2 involved nodes on final histology who would benefit from further axillary treatment.Conclusion:Majority of patients with OSNA detected positive sentinel nodes had low nodal disease burden which could be easily managed with radiotherapy rather than axillary clearance.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}